➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ecopipam

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ecopipam?

Ecopipam is an investigational drug.

There have been 10 clinical trials for Ecopipam. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2012.

The most common disease conditions in clinical trials are Syndrome, Tourette Syndrome, and Self-Injurious Behavior. The leading clinical trial sponsors are Psyadon Pharma, Emalex Biosciences Inc., and William Ondo, MD.

There are eleven US patents protecting this investigational drug and two hundred and ninety-eight international patents.

Recent Clinical Trials for Ecopipam
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label ExtensionEmalex Biosciences Inc.Phase 2
Ecopipam Tablets to Study Tourette's Syndrome in Children and AdolescentsEmalex Biosciences Inc.Phase 2
Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific AntagonistRestless Legs Syndrome FoundationPhase 1/Phase 2

See all Ecopipam clinical trials

Clinical Trial Summary for Ecopipam

Top disease conditions for Ecopipam
Top clinical trial sponsors for Ecopipam

See all Ecopipam clinical trials

US Patents for Ecopipam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ecopipam   Start Trial Tape preparation of WT1 peptide cancer vaccine for transdermal administration NITTO DENKO CORPORATION (Osaka, JP) OSAKA UNIVERSITY (Osaka, JP)   Start Trial
Ecopipam   Start Trial WT1 peptide cancer vaccine composition for mucosal administration NITTO DENKO CORPORATION (Osaka, JP) OSAKA UNIVERSITY (Osaka, JP)   Start Trial
Ecopipam   Start Trial Process for synthesis of D1 receptor antagonists Schering Corporation (Kenilworth, NJ)   Start Trial
Ecopipam   Start Trial Active agent delivery systems and methods for protecting and administering active agents New River Pharmaceuticals Inc. (Radford, VA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ecopipam

Drugname Country Document Number Estimated Expiration Related US Patent
Ecopipam Canada 2841014 2033-02-05   Start Trial
Ecopipam China 103961305 2033-02-05   Start Trial
Ecopipam European Patent Office 2762156 2033-02-05   Start Trial
Ecopipam India 393CH2014 2033-02-05   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.